SEC Filing Details

SEC Filing Details

Document Details

Form
424B5
Filing Date
Nov 10, 2022
Document Date
Nov 10, 2022
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Chinook Therapeutics, Inc.
Issuer
CHINOOK THERAPEUTICS, INC.

IR Contact

Noopur Liffick

Senior Vice President
Investor Relations & Corporate Communications
investors@chinooktx.com

MEDIA CONTACT

Kelly North

Senior Manager
Investor Relations & Corporate Communications
media@chinooktx.com